8.41
0.37 (4.60%)
| Penutupan Terdahulu | 8.04 |
| Buka | 8.04 |
| Jumlah Dagangan | 118,947 |
| Purata Dagangan (3B) | 108,093 |
| Modal Pasaran | 457,565,376 |
| Harga / Buku (P/B) | 1.26 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Nov 2024 |
| EPS Cair (TTM) | -4.39 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 8.93% |
| Nisbah Semasa (MRQ) | 11.26 |
| Aliran Tunai Operasi (OCF TTM) | -163.52 M |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Alumis Inc. | Menurun | - |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.38 |
|
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 1.21% |
| % Dimiliki oleh Institusi | 74.65% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Ayurmaya Capital Management Company, Lp | 30 Sep 2024 | 10,645,965 |
| Foresite Capital Management V, Llc | 30 Sep 2024 | 5,584,889 |
| Samsara Biocapital, Llc | 30 Sep 2024 | 3,266,498 |
| Nextech Invest Ltd. | 30 Sep 2024 | 1,476,998 |
| Yu Fan | 30 Sep 2024 | 789,618 |
| Omega Fund Management, Llc | 30 Sep 2024 | 653,223 |
| Ally Bridge Group (Ny) Llc | 30 Sep 2024 | 418,416 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 26.00 (HC Wainwright & Co., 209.16%) | Beli |
| Median | 25.50 (203.21%) | |
| Rendah | 25.00 (Baird, 197.27%) | Beli |
| Purata | 25.50 (203.21%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 10.07 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 20 Dec 2024 | 26.00 (209.16%) | Beli | 8.82 |
| 14 Nov 2024 | 26.00 (209.16%) | Beli | 9.41 | |
| Baird | 31 Oct 2024 | 25.00 (197.27%) | Beli | 11.32 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |